Omnicell, Inc. (OMCL)
Healthcare • Health Information Services
StockNasdaqGSUnited StatesUS68213N1090
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Omnicell, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 14:02. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 04 Feb 2027 08:00 | 0.42 | — | — | Upcoming |
| 29 Oct 2026 06:00 | 0.42 | 0.58 | +38.9% | Beat |
| 30 Jul 2026 06:00 | 0.47 | 0.94 | +101.1% | Beat |
| 28 Apr 2026 06:00 | 0.33 | 0.55 | +66.0% | Beat |
| 05 Feb 2026 06:00 | 0.50 | 0.40 | -19.4% | Miss |
| 30 Oct 2025 06:00 | 0.36 | 0.51 | +40.7% | Beat |
| 31 Jul 2025 06:00 | 0.27 | 0.45 | +66.7% | Beat |
| 06 May 2025 06:00 | 0.20 | 0.26 | +27.1% | Beat |
| 06 Feb 2025 06:00 | 0.58 | 0.60 | +2.8% | Beat |
| 30 Oct 2024 06:00 | 0.42 | 0.56 | +33.6% | Beat |
| 01 Aug 2024 06:00 | 0.14 | 0.51 | +253.5% | Beat |
| 02 May 2024 07:00 | -0.09 | 0.03 | +132.0% | Beat |
| 08 Feb 2024 08:00 | 0.15 | 0.33 | +114.5% | Beat |
| 02 Nov 2023 08:00 | 0.48 | 0.62 | +30.5% | Beat |
| 01 Aug 2023 16:00 | 0.28 | 0.57 | +101.8% | Beat |
| 02 May 2023 16:00 | 0.07 | 0.39 | +476.7% | Beat |
| 28 Feb 2023 16:00 | 0.08 | 0.33 | +301.4% | Beat |
| 02 Nov 2022 08:00 | 0.95 | 1.00 | +4.8% | Beat |
| 04 Aug 2022 16:00 | 0.85 | 0.84 | -1.2% | Miss |
| 28 Apr 2022 16:00 | 0.68 | 0.83 | +22.1% | Beat |
| 14 Feb 2022 16:00 | 0.92 | 0.92 | -0.3% | In line |
| 02 Nov 2021 07:00 | 0.91 | 1.08 | +18.4% | Beat |
| 29 Jul 2021 08:00 | 0.83 | 0.97 | +17.3% | Beat |
| 29 Apr 2021 16:00 | 0.66 | 0.83 | +26.4% | Beat |
| 01 Feb 2021 16:00 | 0.82 | 0.91 | +11.2% | Beat |
| 27 Oct 2020 16:00 | 0.49 | 0.60 | +23.2% | Beat |
| 28 Jul 2020 16:00 | 0.23 | 0.37 | +63.9% | Beat |
| 07 May 2020 17:00 | 0.51 | 0.66 | +29.0% | Beat |
| 06 Feb 2020 16:00 | 0.78 | 0.77 | -1.5% | Miss |
| 24 Oct 2019 16:00 | 0.71 | 0.76 | +6.8% | Beat |
| 25 Jul 2019 16:00 | 0.63 | 0.67 | +5.6% | Beat |
| 25 Apr 2019 16:00 | 0.41 | 0.61 | +50.4% | Beat |
| 07 Feb 2019 16:00 | 0.67 | 0.70 | +5.2% | Beat |
| 25 Oct 2018 16:00 | 0.56 | 0.63 | +13.4% | Beat |
| 26 Jul 2018 16:00 | 0.39 | 0.46 | +16.7% | Beat |
| 26 Apr 2018 16:00 | 0.25 | 0.29 | +14.7% | Beat |
| 01 Feb 2018 16:00 | 0.52 | 0.54 | +4.1% | Beat |
| 26 Oct 2017 16:00 | 0.42 | 0.42 | +0.7% | In line |
| 27 Jul 2017 16:00 | 0.23 | 0.31 | +32.3% | Beat |
| 04 May 2017 08:00 | 0.02 | 0.06 | +200.0% | Beat |
| 15 Feb 2017 11:00 | 0.41 | 0.37 | -9.8% | Miss |
| 27 Oct 2016 16:00 | 0.41 | 0.40 | -1.5% | Miss |
| 28 Jul 2016 16:00 | 0.32 | 0.38 | +18.8% | Beat |
| 28 Apr 2016 16:00 | 0.26 | 0.35 | +32.4% | Beat |
| 04 Feb 2016 16:00 | 0.39 | 0.40 | +1.8% | Beat |
| 29 Oct 2015 16:00 | 0.36 | 0.36 | -0.4% | In line |
| 30 Jul 2015 16:00 | 0.33 | 0.28 | -14.3% | Miss |
| 30 Apr 2015 16:00 | 0.23 | 0.29 | +24.3% | Beat |
| 03 Feb 2015 16:00 | 0.34 | 0.39 | +15.4% | Beat |
| 30 Oct 2014 16:00 | 0.31 | 0.30 | -3.6% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 1.2B | +6.5% | 2.1M | 0.2% | 0.04 | -85.2% | 69.4M |
| 2024 | 1.1B | -3.0% | 12.5M | 1.1% | 0.27 | +160.0% | 134.9M |
| 2023 | 1.1B | -11.5% | -20.4M | -1.8% | -0.45 | -475.0% | 126.1M |
| 2022 | 1.3B | — | 5.6M | 0.4% | 0.12 | — | 17M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 12 Nov 2026 In progress | 37.85 | 38.34 | 34.82 | 34.95 | -6.40% | 1,748,300 | |
| 02 Nov 2026 – 06 Nov 2026 | 36.78 | 40.10 | 35.19 | 37.34 | +1.88% | 4,166,100 | |
| 26 Oct 2026 – 30 Oct 2026 | 37.73 | 38.50 | 35.45 | 36.65 | -2.91% | 3,684,800 | |
| 19 Oct 2026 – 23 Oct 2026 | 35.39 | 37.83 | 35.12 | 37.75 | +6.67% | 2,513,800 | |
| 12 Oct 2026 – 16 Oct 2026 | 35.87 | 37.32 | 35.07 | 35.39 | -1.20% | 2,065,100 | |
| 05 Oct 2026 – 09 Oct 2026 | 33.07 | 36.05 | 33.07 | 35.82 | +6.61% | 2,415,000 | |
| 28 Sep 2026 – 02 Oct 2026 | 33.21 | 34.46 | 32.70 | 33.60 | -0.18% | 2,523,500 | |
| 21 Sep 2026 – 25 Sep 2026 | 32.43 | 33.73 | 31.98 | 33.66 | +4.44% | 2,426,700 | |
| 14 Sep 2026 – 18 Sep 2026 | 33.23 | 33.63 | 32.04 | 32.23 | -1.71% | 2,809,100 | |
| 08 Sep 2026 – 11 Sep 2026 | 33.75 | 35.30 | 32.12 | 32.79 | -4.60% | 2,056,900 | |
| 253 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Buy These 3 Stocks with Broker Rating Upgrades for Big Gains (opens in a new tab) Zacks · 10 Nov 2026 17:41
- 4 Undervalued Stocks That Could Benefit from a Wall Street Rally (opens in a new tab) Zacks · 10 Nov 2026 17:38
- Learn Why The Bull Case For Omnicell (OMCL) Could Change Following Raised Revenue Guidance (opens in a new tab) Simply Wall St. · 07 Nov 2026 12:12
- Why Omnicell (OMCL) Might be Well Poised for a Surge (opens in a new tab) Zacks · 05 Nov 2026 16:20
- OMCL vs. VEEV: Which Stock Should Value Investors Buy Now? (opens in a new tab) Zacks · 05 Nov 2026 15:40
- Top Robotics Stocks With Strong Potential for Long-Term Growth (opens in a new tab) Zacks · 05 Nov 2026 15:33
- Best Momentum Stocks to Buy for November 5th (opens in a new tab) Zacks · 05 Nov 2026 14:00
- Does Omnicell (OMCL) Have the Potential to Rally 40.83% as Wall Street Analysts Expect? (opens in a new tab) Zacks · 05 Nov 2026 13:55
- New Strong Buy Stocks for November 5th (opens in a new tab) Zacks · 05 Nov 2026 10:27
- Best Value Stocks to Buy for November 5th (opens in a new tab) Zacks · 05 Nov 2026 06:51
- OMCL Q3 deep dive: disciplined cost control offsets flat sales, software transition in early innings (opens in a new tab) StockStory · 02 Nov 2026 22:05
- Omnicell’s Q3 earnings call: our top 5 analyst questions (opens in a new tab) StockStory · 02 Nov 2026 15:25
- Omnicell (OMCL) Q3 Earnings Lift Profit Outlook As Margins Firm (opens in a new tab) Simply Wall St. · 30 Oct 2026 13:12
- Omnicell, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 30 Oct 2026 01:22
- Omnicell Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 29 Oct 2026 21:14
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 35.57 USD
- Market cap
- 1.6B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Health Information Services
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 0.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 8.6 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 20.0 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 10.6 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 10.0 / 10 |
|
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 37.4× | Weak | 30.56× |
| P/E (forward) | 17.87× | Fair | 14.16× |
| Price / book | 1.25× | Good | 3.5× |
| Price / sales | 1.33× | Good | 3.33× |
| EV / EBITDA | 18.25× | Weak | 11.19× |
| Free cash flow yield | 8.3% | Good | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 44.4% | Good | 54.9% |
| Operating margin | 4.9% | Weak | 5.8% |
| Net margin | 3.6% | Weak | 1.2% |
| Return on equity | 3.5% | Weak | 4.4% |
| Return on assets | 1.8% | Weak | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | -2.9% | Weak | 10.1% |
| EPS growth / year | -30.7% | Weak | 10.2% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.15× | Good | 0.4× |
| Net debt / EBITDA | -1.3× | Good | 1.46× |
| Current ratio | 1.66× | Good | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow OMCL and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.